Ephrin A1 anticorps (AA 101-205) (Biotin)
-
- Antigène Voir toutes Ephrin A1 (EFNA1) Anticorps
- Ephrin A1 (EFNA1)
-
Épitope
- AA 101-205
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Ephrin A1 est conjugé à/à la Biotin
-
Application
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Humain
- Homologie
- Mouse,Rat
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human Ephrin A1
- Isotype
- IgG
- Top Product
- Discover our top product EFNA1 Anticorps primaire
-
-
- Indications d'application
-
IHC-P 1:200-400
IHC-F 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- Ephrin A1 (EFNA1)
- Autre désignation
- Ephrin A1 (EFNA1 Produits)
- Synonymes
- anticorps Xefrin-A1, anticorps b61, anticorps ecklg, anticorps efl1, anticorps efna1, anticorps efna1a, anticorps elfa-a, anticorps epha1, anticorps eplg1, anticorps lerk1, anticorps tnfaip4, anticorps xelf-a', anticorps xelfa, anticorps AI325262, anticorps B61, anticorps Efl1, anticorps Epl1, anticorps Eplg1, anticorps Lerk1, anticorps ECKLG, anticorps EFL1, anticorps EPLG1, anticorps LERK-1, anticorps LERK1, anticorps TNFAIP4, anticorps efna1b, anticorps MGC130661, anticorps ephrin-A1 S homeolog, anticorps ephrin-A1, anticorps ephrin A1, anticorps ephrin-A1b, anticorps ephrin-A1 L homeolog, anticorps efna1.S, anticorps efna1, anticorps EFNA1, anticorps efna1b, anticorps Efna1, anticorps efna1.L
- Sujet
-
Synonyms: Ephrin-A1, EFNA1, EPH-related receptor tyrosine kinase ligand 1, LERK-1, Immediate early response protein B61, Tumor necrosis factor alpha-induced protein 4, EPLG1, LERK1, TNFAIP4
Background: Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. Plays an important role in angiogenesis and tumor neovascularization. The recruitment of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly. Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cone and regulates dendritic spine morphogenesis.
- ID gène
- 1942
- UniProt
- P20827
- Pathways
- Signalisation RTK
-